The National Heart, Lung, and Blood Institute‐funded Production Assistance for Cellular Therapies (PACT) program: Eighteen years of cell therapy-Reference-Cited by-同舟云学术

The National Heart, Lung, and Blood Institute‐funded Production Assistance for Cellular Therapies (PACT) program: Eighteen years of cell therapy

Published:2021-07-19 Issue:6 Volume:14 Page:2099-2110
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

El Fiky Ashraf¹,Ibenana Laarni¹,Anderson Robert¹,Hare Joshua M.²,Khan Aisha²,Gee Adrian P.³,Rooney Cliona³,McKenna David H.⁴,Gold Joseph⁵,Kelley Linda⁶,Lundberg Martha S.⁷,Welniak Lisbeth A.⁷,Lindblad Robert¹

Affiliation:

1. The Emmes Company, LLC Rockville Maryland USA

2. Interdisciplinary Stem Cell Institute Miller School of Medicine University of Miami Miami Florida USA

3. Center For Cell and Gene Therapy Baylor College of Medicine Houston Texas USA

4. Molecular and Cellular Therapeutics University of Minnesota Saint Paul Minnesota USA

5. Center for Biomedicine and Genetics City of Hope Duarte California USA

6. Moffitt Cancer Center Tampa Florida USA

7. National Heart, Lung, and Blood Institute Bethesda Maryland USA

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13102

Reference19 articles.

1. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

2. Optimizing the production of suspension cells using the G-Rex “M” series

3. Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections

4. Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

5. Clinical‐scale production of cGMP compliant CD3/CD19 cell‐depleted NK cells in the evolution of NK cell immunotherapy at a single institution

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The expanding role of blood and tissue establishments in the development of advanced therapy medicinal products;Cytotherapy;2024-05